Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy
Open Access
- 16 February 2010
- journal article
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 8 (1) , 2
- https://doi.org/10.1186/1476-7961-8-2
Abstract
Background: Subcutaneous Immunotherapy (SCIT) modifies the allergic response and relieves allergic symptoms. SCIT is the only and a very effective treatment for insect venom allergy. We hypothesized that basophil sensitivity, measured through the basophil activation test, would decrease during SCIT up dosing. Expression of CD203c was compared to CD63 as marker for basophil activation, using a Bland Altman plot and ROC curves. Methods: Patients (n = 18) starting subcutaneous SCIT for wasp allergy with an up dosing scheme of 7 to 11 weeks were enrolled. Heparinised blood samples were drawn at weeks 1-4, 7 and at the first maintenance visit. Basophils were stimulated at 7 log dilutions of V. vespula allergen for 15 min, and were stained with CD203c and CD63. Basophils were identified as CD203c+ leukocytes, and the proportion of CD63+ and CD203c+ cells were plotted against allergen concentration. A sigmoid curve was fitted to the points, and the allergen concentration at which half of the maximal activation was achieved, LC50, was calculated. In another series of experiments, LC50 calculated in whole blood (AP) was subtracted from LC50 calculated with basophils suspended in plasma from a nonatopic donor (HS) to determine the protective effect of soluble factors in blood of patients treated with SCIT. Results: Heparin blood basophil activation was similar through CD63 and CD203c. Basophils were significantly more sensitized three weeks after initiation of SCIT compared to baseline (p < 0,01). The difference in LC50 increased by 1,04 LC50 units (p = 0,04) in patients that had just achieved maintenance dose compared with patients before initiating SCIT. When maintenance allergen concentrations had been reached, an increase in the protective plasma component was documented. Blood basophil concentration was marginally reduced by SCIT. Conclusion: Basophil activation is a versatile and sensitive tool that measures changes in the humoral immune response to allergen during SCIT.Keywords
This publication has 28 references indexed in Scilit:
- CD‐sens: a biological measure of immunological changes stimulated by ASITAllergy, 2009
- Allergen-Induced Basophil CD203c Expression as a Biomarker for Rush Immunotherapy in Patients with Japanese Cedar PollinosisInternational Archives of Allergy and Immunology, 2008
- Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activityPublished by Elsevier ,2008
- Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforceAllergy, 2007
- Basophil Interleukin 4 and Interleukin 13 Production Is Suppressed during the Early Phase of Rush ImmunotherapyInternational Archives of Allergy and Immunology, 2006
- Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluationAllergy, 2006
- High sensitivity of basophils predicts side‐effects in venom immunotherapyAllergy, 2005
- Lysis with Saponin improves detection of the response through CD203c and CD63 in the basophil activation test after crosslinking of the high affinity IgE receptor FcεRIClinical and Molecular Allergy, 2005
- Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venomJournal of Allergy and Clinical Immunology, 2002
- Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysisClinical Therapeutics, 2000